摘要
目的观察莫西沙星序贯治疗急性肺炎患者的临床治疗效果。方法采用莫西沙星注射液400 mg,每日1次静脉滴注,症状明显改善后改为片剂口服继续治疗,疗程为7～10 d。完成病例52例,观察治疗前后症状、细菌学、药敏情况与并发症。结果治疗有效率、细菌清除率、不良反应发生率分别为90.91%、93.94%、9.09%。结论莫西沙星序贯治疗急性肺炎安全、有效,有较高的临床价值。
Objective To observe the clinical effect of sequential therapy of moxifloxacin on acute pneumonia.Methods Fifty-two patients were treated with moxifloxacin,400 mg once a day.Then congeneric medicine orally were given when their symptoms of disease were improved.Symptoms,bacteriology,drug sensitiveness were observed respectively before and after treatment.Results The effective rate,bacterial clearing rate and occurrence of the adverse reactions were 90.91%,93.94%,9.09% respectively.Conclusion Moxifloxacin is a safe and efficient kind of antibiotics in sequential therapy with acute pneumonia.
出处
《临床医学》
CAS
2010年第9期17-18,共2页
Clinical Medicine
关键词
莫西沙星
急性肺炎
序贯疗法
Moxifloxacin
Pneumonia
Sequential therapy
